Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.33
-1.55 (-10.39%)
At close: Oct 30, 2026, 4:00 PM EDT
13.32
0.00 (-0.04%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $1.12 billion as of October 30, 2026. It is the 9,296th most valuable company in the world and the 2,161st biggest in the United States. Its market cap has increased by 141.37% in one year.
Market Cap
1.12B
Enterprise Value
1.35B
1-Year Change
141.37%
Global Rank
Country Rank
#2,161 United States
Category
ChartMarket Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $1.12B, an increase of 57.05%. That is a compound annual growth rate of 8.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 1.02B | 103.83% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tandem Diabetes Care | 1.33B |
| CONMED | 1.32B |
| Enovis | 1.15B |
| Artivion | 1.10B |
| PROCEPT BioRobotics | 1.10B |
| Lumexa Imaging Holdings | 1.10B |
| Alphatec Holdings | 1.09B |
| CeriBell | 1.02B |